Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro.

PubWeight™: 2.19‹?› | Rank: Top 2%

🔗 View Article (PMC 2186919)

Published in J Exp Med on February 01, 1983

Authors

H Kawanishi, L E Saltzman, W Strober

Articles citing this

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28

Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med (1989) 2.12

Induction of immunoglobulin isotype switching in cultured I.29 B lymphoma cells. Characterization of the accompanying rearrangements of heavy chain genes. J Exp Med (1985) 1.59

Clonal analysis of B cells induced to secrete IgG by T cell-derived lymphokine(s). J Exp Med (1984) 1.58

Human malignant T cells capable of inducing an immunoglobulin class switch. J Exp Med (1985) 1.56

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells. J Exp Med (1983) 1.33

Isotype specificity of helper T cell clones. Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med (1984) 1.31

Isotype-specific immunoregulation. IgA-binding factors produced by Fc alpha receptor-positive T cell hybridomas regulate IgA responses. J Exp Med (1985) 1.17

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut. Virology (2011) 1.15

The induction and migration of antigen-specific helper cells for IgA responses in the intestine. Immunology (1986) 1.14

Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol (2002) 1.13

Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. Immunology (1989) 1.10

Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin. Infect Immun (1989) 1.10

Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease. Am J Pathol (1985) 1.06

Distribution and functional characteristics of antigen-specific helper T cells arising after Peyer's patch immunization. Immunology (1987) 1.05

In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease. Clin Exp Immunol (1984) 1.03

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes. J Virol (1999) 1.03

Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol (1994) 1.00

The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. II. Peripheral intestinal lymph as a source of IgA producing cells. Clin Exp Immunol (1984) 1.00

Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol (1991) 0.99

Immunoglobulin G (IgG) and IgA subclass pattern of human antibodies to Shigella flexneri and Salmonella serogroup B and D lipopolysaccharide O antigens. Infect Immun (1986) 0.99

Increase of IgA-specific switch T cells in patients with IgA nephropathy. Clin Exp Immunol (1989) 0.97

Surface expression of differentiation antigens on lymphocytes in the ileal and jejunal Peyer's patches of lambs. Immunology (1989) 0.93

Vicia villosa agglutinin separates freshly isolated Peyer's Patch T cells into interleukin 5- or interleukin 2-producing subsets. J Exp Med (1989) 0.93

Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Vaccine (2010) 0.93

T cells expressing the V beta 1 T-cell receptor are required for IgA production in the chicken. Proc Natl Acad Sci U S A (1991) 0.91

Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri. Infect Immun (1988) 0.91

A subset of Ly-1 inducer T cell clones activates B cell proliferation but directly inhibits subsequent IgG secretion. J Exp Med (1985) 0.90

Intra-intestinal priming leads to antigen-specific IgA memory cells in peripheral lymphoid organs. Immunology (1985) 0.89

Background (spontaneous) immunoglobulin production in the murine small intestine as a function of age. Immunology (1988) 0.87

Limited expression of APRIL and its receptors prior to intestinal IgA plasma cell development during human infancy. Mucosal Immunol (2013) 0.87

Cognate T-cell help in the induction of IgA responses in vivo. Immunology (1990) 0.86

In vitro induction of a contrasuppressor immunoregulatory network by polyclonally activated T cells derived from murine Peyer's patches. Immunology (1988) 0.82

Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. J Clin Invest (1985) 0.80

Distribution of lymphocyte subsets in the large intestinal lymphoid follicles of lambs. Immunology (1990) 0.80

Lymphocyte proliferation in Peyer's patches of Giardia muris-infected mice. Infect Immun (1990) 0.80

Effect of IL-2 on immunoregulatory function of intestinal lamina propria T cells in normal non-human primates. Clin Exp Immunol (1987) 0.79

Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization. Immunology (1989) 0.79

IgA antibodies in the bile of rats. IV. Synthesis of secretory antibodies in irradiated rats reconstituted with spleen cells: influence of microenvironment on the regulation of IgA production. Immunology (1984) 0.78

Distribution of immunoglobulin-containing cells in normal and neonatally thymectomized rats. Infect Immun (1983) 0.78

A novel mechanism for the selection of isotype-specific antibody responses: the role of intestinal T cells in the regulation of IgA synthesis by the anti-suppressor circuit. Immunology (1988) 0.78

Immunocompetence of normal human appendiceal lymphoid cells: in vitro studies. Immunology (1987) 0.77

T-cell control of IgA production. I. Distribution, activation conditions and culture of isotype-specific regulatory helper cells. Immunology (1985) 0.77

Modulation of murine Peyer's patch immunoglobulin A response by enterotoxigenic Escherichia coli. Infect Immun (1987) 0.75

Apoptosis by CD95 (Fas)-dependent and -independent mechanisms in Peyer's patch lymphocytes in murine retrovirus-induced immunodeficiency syndrome. J Virol (1996) 0.75

The influence of Peyer's patches on the organ-specific distribution of IgA plasma cells. Immunology (1988) 0.75

Regulation of mucosal immune responses: distinct antigens and antigen presenting cells. J Clin Immunol (1997) 0.75

Articles cited by this

Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92

Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods (1977) 8.43

Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med (1971) 5.83

T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med (1982) 4.51

The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J Exp Med (1978) 4.01

Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc Natl Acad Sci U S A (1978) 3.95

B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor. J Exp Med (1981) 3.40

T-cell regulation of murine IgA synthesis. J Exp Med (1979) 3.11

Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol (1978) 2.86

Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. Cell (1981) 2.84

Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol (1978) 2.69

Ordering of mouse immunoglobulin heavy chain genes by molecular cloning. Nature (1981) 2.28

Interleukin 2: a class of T cell growth factors. Immunol Rev (1980) 2.21

Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06

Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J Immunol (1981) 2.03

T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch. J Exp Med (1982) 1.88

Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev (1980) 1.76

Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73

Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load. J Exp Med (1979) 1.72

Successive switching of antibody isotypes expressed within the lines of a B-cell clone. Proc Natl Acad Sci U S A (1980) 1.53

Immunoglobulin class switching: developmentally regulated DNA rearrangements during differentiation. Cell (1980) 1.46

Microenvironmental immunoregulation: possible role of contrasuppressor cells in maintaining immune responses in gut-associated lymphoid tissues. Proc Natl Acad Sci U S A (1982) 1.37

Studies of surface immunoglobulins on human B lymphocytes. II. Characterization of a population of lymphocytes lacking surface immunoglobulins but carrying Fc receptor (SIg-Fc+ cell). J Immunol (1976) 1.11

Murine T cell Ia antigens. II. Further studies on an I-J subregion specificity. J Immunol (1979) 0.93

In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells. Cell Immunol (1980) 0.92

Articles by these authors

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med (2001) 8.69

Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet (1974) 8.13

Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol (1996) 6.21

Metabolism of immunoglobulins. Prog Allergy (1969) 5.74

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09

Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med (1975) 3.81

Prevalence of violence against pregnant women. JAMA (1996) 3.73

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med (1998) 3.50

The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43

Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int (2000) 3.20

T-cell regulation of murine IgA synthesis. J Exp Med (1979) 3.11

Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest (1972) 3.09

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med (1967) 3.06

Screening for intimate partner violence by health care providers. Barriers and interventions. Am J Prev Med (2000) 3.04

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92

Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest (1966) 2.91

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68

The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol (1976) 2.65

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61

NIH conference. New insights into common variable immunodeficiency. Ann Intern Med (1993) 2.52

Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50

Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol (1993) 2.48

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol (2001) 2.42

Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med (1996) 2.38

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med (1996) 2.30

Dermatitis herpetiformis: the skin and the gut. Ann Intern Med (1980) 2.24

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med (1999) 2.20

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med (1996) 2.17

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity (1995) 2.17

TNBS-colitis. Int Rev Immunol (2000) 2.17

The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol (1979) 2.15

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07

Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03

Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J Immunol (1981) 2.03

Incorporation of L-leucine-14C into immunoglobulins by jejunal biopsies of patients with celiac sprue and other gastrointestinal diseases. J Clin Invest (1971) 2.01

Attempted suicide among young adults: progress toward a meaningful estimate of prevalence. Am J Psychiatry (1992) 1.97

Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88

Gluten-sensitive enteropathy: synthesis of antigliadin antibody in vitro. Gut (1974) 1.87

Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) (2001) 1.86

Violence and adverse pregnancy outcomes: a review of the literature and directions for future research. Am J Prev Med (1997) 1.85

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology (1999) 1.78

Violence and reproductive health: current knowledge and future research directions. Matern Child Health J (2000) 1.77

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest (1998) 1.77

Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med (1989) 1.77

An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture. J Clin Invest (1974) 1.74

The role of IL-5 in IgA B cell differentiation. J Immunol (1988) 1.73

The pathogenesis of dermatitis herpetiformis. J Invest Dermatol (1978) 1.70

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest (1972) 1.70

Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest (1984) 1.68

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol (2010) 1.65

A receptor for IgA on human T lymphocytes. J Immunol (1979) 1.65

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci U S A (1999) 1.63

Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60

Characteristics and regulatory function of murine con A-induced, cloned T cells obtained from Peyer's patches and spleen: mechanisms regulating isotype-specific immunoglobulin production by Peyer's patch B cells. J Immunol (1982) 1.57

Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol (1998) 1.56

Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol (1998) 1.55

Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med (2000) 1.54

Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol (2001) 1.52

Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med (1976) 1.52

Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology (1986) 1.50

High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol (1996) 1.49

Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol (1990) 1.46

Increased jejunal immunoglobulin synthesis in patients with nontropical sprue as measured by a solid phase immunoadsorption technique. J Lab Clin Med (1972) 1.46

Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci (1998) 1.46

The immunologic basis of inflammatory bowel disease. J Clin Immunol (1986) 1.45

Intimate partner violence against women: do victims cost health plans more? J Fam Pract (1999) 1.45

Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int (2000) 1.44

Self-reported childhood and adolescent sexual abuse among adult homosexual bisexual men. Child Abuse Negl (1993) 1.44

Deficient IgA antibody responses to arsanilic acid bovine serum albumin (BSA) in neonatally thymectomized rabbits. J Immunol (1971) 1.43

The relationship between pregnancy intendedness and physical violence in mothers of newborns. The PRAMS Working Group. Obstet Gynecol (1995) 1.42

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. J Virol (1998) 1.42

The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin. Am J Med (1969) 1.42

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42

Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol (1998) 1.41

Immunoglobulin A production in ataxia telangiectasia. Science (1965) 1.41

Secretory component deficiency. A disorder of the IgA immune system. N Engl J Med (1976) 1.41

Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits. J Invest Dermatol (1980) 1.41

Massachusetts Weapon-Related Injury Surveillance System. Am J Prev Med (1998) 1.40

Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.40

Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol (2000) 1.39

Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest (1968) 1.38

Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology (1980) 1.36

NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med (1983) 1.35

Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci (1996) 1.34

A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun (2002) 1.33

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells. J Exp Med (1983) 1.33

Cholera toxin promotes B cell isotype differentiation. J Immunol (1989) 1.32